Device Trial Radar · NCT07717866
Trifecta Research Study
Last checked: Nov 20, 2026Latest source record: Jul 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
52
Actual
Start
Aug 1, 2022
Primary completion
Feb 1, 2026
Study completion Nov 2026
Sponsor
- Lead sponsor
- Axial Therapeutic ResearchNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 21, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This observational study evaluates the impact of Ibogaine-Magnesium (IM), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), Magnetic e-Resonance Therapy (MeRT), and Physiological Supplementation (PS) on posttraumatic stress disorder (PTSD) and traumatic brain injury-related cognitive symptoms among Special Operations Forces (SOF) combat veterans.
Conditions
- PTSD - Post Traumatic Stress Disorder
- Cognitive Dysfunction
- Brain Injury
- Depression - Major Depressive Disorder
- Suicidal Ideation
Interventions
Magnetic e-Resonance Therapy (MeRT)Device
MeRT, an electroencephalography (EEG)-guided Repetitive Transcranial Magnetic Stimulation therapy, is a non-invasive treatment that uses magnetic pulses to modulate neural networks of the brain, guided by an individual's brain patterns. MeRT is a neuromodulatory tool that has shown therapeutic efficacy in relation to decreasing severity of PTSD symptoms. There is preliminary data showing MeRT's therapeutic impact on depression and TBI-related cognitive impairment through promoting cortical excitability, modulating neurotransmission, and restoring neuroplasticity.
Ibogaine Hydrochloride with Magnesium SulfateDrug
Ibogaine hydrochloride was administered orally. Ibogaine is an indole alkaloid that together with its metabolites interacts with mu opioid, kappa opioid, N-methyl-D-aspartate receptor (NMDA), and nicotinic acetylcholine receptors. Ibogaine has shown early signs of effectiveness as a rapid-acting treatment for a number of mental health disorders including PTSD and substance use disorder. Magnesium sulfate was administered intravenously prior to Ibogaine administration and orally each day.
5-methoxy-N,N-dimethyltryptamineDrug
5-MeO-DMT is administered by using a pipe to inhale a vapor that is produced by heating a canister containing a powder form of the substance. 5-MeO-DMT is a 5-HT-1A and 5-HT-2A agonist compound that has shown early signs of effectiveness in treating depression. Inhaled 5-MeO-DMT has a short duration of action, producing an intense, time-limited psychoactive state.
Physiological SupplementationDrug
Physiological Supplementation describes a treatment program aimed at restoring healthy endocrine functioning, using supplements such as the following: Synthetic testosterone, Anastrozole, Gonadorelin, Vitamin and amino acid supplementation, Fish oil, Ipamorelin.
Primary outcomes
What the sponsor says the trial is designed to measure.
- PTSD Checklist for Diagnostic and Statistical Manual (DSM)-5 (PCL-5)Time frame: Up to 12 months follow up
- Medical Outcomes Study Cognitive Functioning Scale (MOS-CF)Time frame: Up to 12 months follow up
- Stroop Squared TaskTime frame: Up to 12 months follow-up
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Axial Therapeutic Research
Northridge, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.